We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$245M
AUM Growth
+$30.5M
Cap. Flow
+$8.23M
Cap. Flow %
3.36%
Top 10 Hldgs %
44.48%
Holding
554
New
71
Increased
95
Reduced
70
Closed
60

Top Sells

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$587K
2
AKAM icon
Akamai
AKAM
+$424K
3
CHRW icon
C.H. Robinson
CHRW
+$399K
4
TWLO icon
Twilio
TWLO
+$393K
5
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$311K

Sector Composition

Rank Sector Weight
1 Miscellaneous 80.21%
2 Technology 7.58%
3 Communication Services 2.35%
4 Industrials 2.12%
5 Financials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
476
Beam Therapeutics
BEAM
$2.5B
$515 ﹤0.01%
15
HYLN icon
477
Hyliion Holdings
HYLN
$697M
$485 ﹤0.01%
+93
New +$387
AMRC icon
478
Ameresco
AMRC
$1.27B
$469 ﹤0.01%
+17
New +$492
TXG icon
479
10x Genomics
TXG
$8.96B
$460 ﹤0.01%
12
CGNT icon
480
Cognyte Software
CGNT
$590M
$404 ﹤0.01%
46
-53
-54% -$503
MTLS
481
Materialise
MTLS
$444M
$394 ﹤0.01%
53
SSYS icon
482
Stratasys
SSYS
$679M
$342 ﹤0.01%
40
PD icon
483
PagerDuty
PD
$1.1B
$309 ﹤0.01%
32
PATH icon
484
UiPath
PATH
$7.19B
$304 ﹤0.01%
28
U icon
485
Unity
U
$19.4B
$286 ﹤0.01%
10
NTLA icon
486
Intellia Therapeutics
NTLA
$1.65B
$203 ﹤0.01%
12
PACB icon
487
Pacific Biosciences
PACB
$404M
$161 ﹤0.01%
96
TDOC icon
488
Teladoc Health
TDOC
$1.12B
$127 ﹤0.01%
15
VSNT
489
DELISTED
VERSANT CORP NEW
VSNT
$72 ﹤0.01%
2
ANGI icon
490
Angi Inc
ANGI
$191M
$42 ﹤0.01%
7
TSP
491
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$16 ﹤0.01%
66
ABNB icon
492
Airbnb
ABNB
$100B
-27
Closed -$3.41K
ADCT icon
493
ADC Therapeutics
ADCT
$135M
-1,119
Closed -$4.2K
AEO icon
494
American Eagle Outfitters
AEO
$2.5B
-237
Closed -$3.96K
AIZ icon
495
Assurant
AIZ
$13.9B
-1,289
Closed -$281K
AL
496
DELISTED
Air Lease Corp
AL
-73
Closed -$4.74K
APEI icon
497
American Public Education
APEI
$819M
-79
Closed -$4.49K
AQN icon
498
Algonquin Power & Utilities
AQN
$4.07B
-10,187
Closed -$62.5K
ARQT icon
499
Arcutis Biotherapeutics
ARQT
$3.01B
-4,026
Closed -$94.9K
ARVN icon
500
Arvinas
ARVN
$562M
-53
Closed -$562

Similar funds

C.M. Bidwell & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, C.M. Bidwell & Associates held 554 positions worth $245M, up 14% from $214M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

C.M. Bidwell & Associates deployed $8.23M of net new capital in Q2 2026, opening 71 new positions and adding to 95 existing holdings. Its largest new stake was Dow Inc: 15,138 shares worth $414K.

By sector, the portfolio is most concentrated in Miscellaneous at 80% of assets, down from 82% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Vertiv, an estimated $587K trimmed.

  • C.M. Bidwell & Associates's largest Q2 2026 buy was Dow Inc: 15,138 shares worth $414K.
  • C.M. Bidwell & Associates added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.23M increase.
  • C.M. Bidwell & Associates's biggest Q2 2026 reduction was Vertiv, cutting an estimated $587K.
  • C.M. Bidwell & Associates fully exited C.H. Robinson in Q2 2026, selling an estimated $399K.
  • C.M. Bidwell & Associates's ten largest holdings make up 44% of its $245M portfolio in Q2 2026.
  • C.M. Bidwell & Associates opened 71 new positions and closed 60 in Q2 2026.
  • C.M. Bidwell & Associates's portfolio value rose 14% quarter-over-quarter to $245M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.